Business Standard

Analysts' corner

Dr Reddy's Labs & Indraprastha Gas

Related News

DR REDDY’S LABS
Reco price: Rs 1,709;
Target price: Rs 1,950
Dr Reddy’s (DRRD) has filed an abbreviated new drug application for singulair granules oral formulation, used for treatment of asthma in children. Innovator Merck has sued DRRD for infringement of a patent on this, which expires in October 2022. This product has $80 million annual sales in the US. DRRD can launch earliest in September 14, after expiry of a 30-month stay on generic launch. Mylan and Teva could be the first to file on this product. Overweight.

HSBC Global Research

INDRAPRASTHA GAS
Reco price: Rs 346;
Target price: Rs 426
The Petroleum and Natural Gas Regulatory Board (PNGRB) has issued an order on network rates and compression charge for (IGL);. Against IGL’s proposed Rs 7.8/scm of network rate and compression charge, the PNGRB has allowed a mere Rs 3.1/scm, a decline of Rs 4.7/scm. Even after allowing for a marketing margin over and above this (the quantum of which, however, is uncertain), the order comes as a significant negative surprise, leading to a potential downside of 45-65 per cent to Citigroup’s Ebitda. Under this scenario, IGL will struggle to make even normative returns on the capital it has invested in the business. Maintain buy.

Citigroup

Read more on:   
|

Read More

Axis Bank: Concerns reflect in valuations

Axis Bank posted good set of numbers for the quarter ended 31st March 2012, beating the consensus estimates. Higher than expected growth in interest ...

Quick Links

 

Market News

More lent to Shiv-Vani despite court order

The developments could complicate matters for the company, whose Rs 200-crore term loan from Bank of Maharashtra, a member of the consortium, is ...

Nifty hits 8,100 while Sensex holds 27,000

HDFC twins, Cipla and Sun Pharma were the top gainers

SPML Infra gains 5% on Rs 1,232 crore new orders

The company has won new orders worth Rs 1,232 crore from Uttar Pradesh Jal Nigam, Agra and Sardar Sarovar Narmada Nigam, Gandhinagar.

Punj Lloyd up 5% on talk of stake sale in Medanta Medicity

Meanwhile, the board is schedule to meet tomorrow to consider private placement of non convertible debentures, subordinated debt instruments and ...

Soyabean down 1% on weak global cues

Market analysts attributed fall in soyabean prices at futures trade to offloading of positions by speculators, tracking a weak trend overseas

Back to Top